NCT07118332View on ClinicalTrials.gov

Psilocybin as a Treatment for Chronic Pain in Smokers

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

December 1, 2027

Conditions

Smokers With Chronic Pain

Interventions

DRUG

Psilocybin (drug)

25mg of Psilocybin will be given to all subject

Trial Locations (1)

06516

Department of Veterans Affairs, West Haven

All Listed Sponsors

lead

Yale University

OTHER